Bicara Therapeutics Inc. ...

NASDAQ: BCAX · Real-Time Price · USD
11.44
0.03 (0.26%)
At close: Aug 15, 2025, 12:35 PM

Bicara Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Net Income
-27.39M -36.85M -20.96M -17.48M -14.78M -14.78M -12.44M -22.84M -8.35M -8.35M
Depreciation & Amortization
19K 19K 15K 15K 13K 13K 14K 2K 1.5K 1.5K
Stock-Based Compensation
3.49M 3.45M 3.18M 2.03M 1.09M 1.09M 765K 519K 307.5K 307.5K
Other Working Capital
451K 3.97M -16.28M -180K -155.5K -155.5K 2.94M -1.56M -440K -440K
Other Non-Cash Items
211K 138K -276K 68K 920.5K -758.5K 681K 13.35M -5.05M -5.05M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.93M 5.13M -11.99M -1.86M -155.5K -155.5K 2.94M -1.56M -440K -440K
Operating Cash Flow
-25.59M -28.11M -30.03M -17.22M -12.91M -14.59M -8.04M -10.53M -13.53M -13.53M
Capital Expenditures
n/a n/a -40K -8K -11.5K -11.5K -436K -150K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -7.5K 69.5K n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -40K -8K -19K 58K -436K -150K n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 77K n/a n/a n/a n/a 84K 18.95M 18.95M
Financial Cash Flow
135K 460K -975K 334.13M 734K 137K 194.7M 39.9M 18.95M 18.95M
Net Cash Flow
-25.46M -27.65M -31.05M 316.9M 203.85M -14.39M 186.23M 29.22M 14.99M n/a
Free Cash Flow
-25.59M -28.11M -30.07M -17.23M -13.76M -13.76M -8.47M -10.68M -13.53M -13.53M